scholarly article | Q13442814 |
P819 | ADS bibcode | 2008PNAS..105.9799K |
P356 | DOI | 10.1073/PNAS.0711717105 |
P932 | PMC publication ID | 2474506 |
P698 | PubMed publication ID | 18621678 |
P5875 | ResearchGate publication ID | 5230192 |
P50 | author | Michel Ferrari | Q20518451 |
Martin Dichgans | Q30422338 | ||
Arn van den Maagdenberg | Q42539192 | ||
P2093 | author name string | Alfred L George | |
Thomas H Rhodes | |||
Kristopher M Kahlig | |||
Tobias Freilinger | |||
Michael Pusch | |||
José M Pereira-Monteiro | |||
P2860 | cites work | Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2 | Q22253421 |
Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2 | Q24293004 | ||
Sodium channel dysfunction in intractable childhood epilepsy with generalized tonic-clonic seizures | Q24544180 | ||
Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy | Q24563329 | ||
Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2 | Q28188391 | ||
Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A | Q28191292 | ||
Molecular basis of an inherited epilepsy | Q28207595 | ||
Comparative distribution of voltage-gated sodium channel proteins in human brain | Q28211443 | ||
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression | Q28248603 | ||
Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine | Q28264653 | ||
A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for beta subunit interaction | Q28291611 | ||
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4 | Q28295213 | ||
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy | Q28585126 | ||
Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation | Q28587835 | ||
The International Classification of Headache Disorders: 2nd edition | Q29547231 | ||
Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels | Q34016936 | ||
Expression and distribution of voltage-gated sodium channels in the cerebellum | Q34535787 | ||
Recent advances in understanding migraine mechanisms, molecules and therapeutics | Q34586517 | ||
Pathophysiology of the migraine aura. The spreading depression theory | Q34724476 | ||
Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes | Q35645397 | ||
Localization of voltage-gated ion channels in mammalian brain | Q35672531 | ||
Migraine: gene mutations and functional consequences | Q36818663 | ||
The brain is hyperexcitable in migraine | Q37012139 | ||
Amino acid residues required for fast Na(+)-channel inactivation: charge neutralizations and deletions in the III-IV linker | Q37301144 | ||
A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation | Q37301303 | ||
Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. | Q40603141 | ||
PI 3-kinase regulation of dopamine uptake. | Q40725010 | ||
Cocaine increases dopamine uptake and cell surface expression of dopamine transporters | Q40753544 | ||
Novel clustering of sodium channel Na(v)1.1 with ankyrin-G and neurofascin at discrete sites in the inner plexiform layer of the retina. | Q46410463 | ||
Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain | Q48140249 | ||
The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online | Q48223071 | ||
A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities | Q49049294 | ||
Distal initiation and active propagation of action potentials in interneuron dendrites. | Q51423031 | ||
First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. | Q51819010 | ||
Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy. | Q53592417 | ||
Increased risk of migraine with typical aura in probands with familial hemiplegic migraine and their relatives | Q57024628 | ||
Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons | Q69366003 | ||
Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy | Q74361012 | ||
Migraine | Q74452893 | ||
Polarized distribution of ion channels within microdomains of the axon initial segment | Q79366632 | ||
Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ channel mutant | Q81421178 | ||
Regulation of dopamine transporter trafficking by intracellular amphetamine | Q83310116 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 28 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | migraine | Q133823 |
familial hemiplegic migraine | Q3312899 | ||
P304 | page(s) | 9799-9804 | |
P577 | publication date | 2008-07-09 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Divergent sodium channel defects in familial hemiplegic migraine | |
P478 | volume | 105 |
Q92942241 | Advances in genetics of migraine |
Q38828065 | Animal models of monogenic migraine |
Q34020942 | Antiepileptic activity of preferential inhibitors of persistent sodium current |
Q33684226 | Biological science of headache channels |
Q42219555 | CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice |
Q33680269 | Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models. |
Q38080592 | Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine |
Q37408962 | Early-onset familial hemiplegic migraine due to a novel SCN1A mutation |
Q37786731 | Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again |
Q57949541 | Familial hemiplegic migraine due to L263V SCN1A mutation: Discordance for epilepsy between two kindreds from Douro Valley |
Q92270665 | First FHM3 mouse model shows spontaneous cortical spreading depolarizations |
Q39167599 | Genetics of Migraine: Insights into the Molecular Basis of Migraine Disorders. |
Q37786254 | Hereditary Channelopathies in Neurology |
Q37868982 | Identification of molecular genetic factors that influence migraine. |
Q35226085 | Inherited neuronal ion channelopathies: new windows on complex neurological diseases |
Q50998138 | Intrinsic neuronal excitability: implications for health and disease. |
Q36568513 | Mechanism of sodium channel NaV1.9 potentiation by G-protein signaling |
Q34981965 | Molecular genetics of migraine |
Q26800090 | Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels |
Q33667400 | Multiplexed transposon-mediated stable gene transfer in human cells |
Q37960093 | Na+ channelopathies and epilepsy: recent advances and new perspectives. |
Q46374782 | Neurology--the next 10 years |
Q38179996 | Neuronal calcium signaling: function and dysfunction |
Q34057763 | New directions in migraine |
Q37256074 | Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects |
Q36451955 | Nontruncating SCN1A mutations associated with severe myoclonic epilepsy of infancy impair cell surface expression |
Q37424570 | Novel SCN3A variants associated with focal epilepsy in children |
Q24622323 | Pain as a channelopathy |
Q38106687 | Pearls and pitfalls in genetic studies of migraine |
Q38728979 | Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes |
Q41121995 | Ranolazine selectively blocks persistent current evoked by epilepsy‐associated NaV1.1 mutations |
Q42088430 | SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs |
Q57306574 | SCN1A variants associated with sudden infant death syndrome |
Q91540692 | SCN1A variants from bench to bedside-improved clinical prediction from functional characterization |
Q30828822 | SCN8A mutation in a child presenting with seizures and developmental delays |
Q38071198 | Seeing the forest through the trees: towards a unified view on physiological calcium regulation of voltage-gated sodium channels |
Q37681340 | Sodium channelopathies and pain |
Q37860502 | Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management |
Q34658774 | Studies on the pathophysiology and genetic basis of migraine. |
Q26744657 | The Revolution in Migraine Genetics: From Aching Channels Disorders to a Next-Generation Medicine |
Q33157223 | The borderland of epilepsy: clinical and molecular features of phenomena that mimic epileptic seizures |
Q45047442 | Two novel SCN1A mutations identified in families with familial hemiplegic migraine |
Q37714086 | Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. |
Q38026557 | Voltage-gated sodium channels: biophysics, pharmacology, and related channelopathies. |
Q41894542 | What activates inactivation? |
Search more.